Skip to content

APOTHEEK SLABBINCK: what changed

What changed

APOTHEEK SLABBINCK

BE 0468.817.430
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€8,038
2024 · €28,259-€36,297
Equity
€54,478
2024 · €62,516-€8,038
Cash
€32,777
2024 · €15,175+€17,602
Balance sheet total
€181,970
2024 · €149,116+€32,854

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€24,413

    up €24,413 (+57.5%), from €42,482 to €66,895

    of which Trade receivables: +€13,289

  • Cash +€17,602

    up €17,602 (+116%), from €15,175 to €32,777

    mainly Other debts (+€36,069) and Trade debts (+€29,636)

  • Deferred charges and accrued income -€8,555

    down €8,555 (-97.8%), from €8,744 to €189

  • Tangible fixed assets -€2,893

    down €2,893 (-62.6%), from €4,625 to €1,732

    of which Plant, machinery and equipment: -€2,646

  • Stocks and contracts +€2,287

    up €2,287 (+2.9%), from €78,030 to €80,317

Equity and liabilities
  • Other debts +€36,069

    up €36,069 (+124%), from €29,031 to €65,100

  • Trade debts +€29,636

    up €29,636 (+163%), from €18,203 to €47,838

  • Current portion of long-term debt -€18,002

    down €18,002 (-91.5%), from €19,675 to €1,673

  • Reserves -€8,038

    down €8,038 (-14.5%), from €55,516 to €47,478

  • Tax, wage and social debts -€4,514

    down €4,514 (-29.8%), from €15,155 to €10,640

    of which Taxes: -€4,730

Income statement
  • Gross operating margin -€48,419

    down €48,419 (-48.5%), from €99,883 to €51,464

  • Taxes -€11,477

    no longer reported in 2025 (was €11,477)

  • Staff costs +€2,788

    up €2,788 (+5.7%), from €49,177 to €51,965

  • Financial charges -€1,545

    down €1,545 (-24.2%), from €6,389 to €4,844

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €28,259
Gross operating margin -€48,419
Staff costs -€2,788
Depreciation -€121
Write-downs -€322
Other operating charges -€41
Other operating items +€1,461
Financial income +€911
Financial charges +€1,545
Taxes +€11,477
Result 2025 -€8,038
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€37,277
Investment €0
Financing -€19,675
Cash 2024 €15,175
Net result for the year -€8,038
Depreciation +€2,893
Stocks and contracts -€2,287
Receivables within one year -€24,413
Deferred charges and accrued income +€8,555
Trade debts +€29,636
Tax, wage and social debts -€4,514
Other debts +€36,069
Accrued charges and deferred income -€622
Debts after one year -€1,673
Current portion of long-term debt -€18,002
Cash 2025 €32,777
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €149,116 €181,970 +€32,854 +22.0%
Fixed assets 21/28 €4,685 €1,792 -€2,893 -61.7%
Tangible fixed assets 22/27 €4,625 €1,732 -€2,893 -62.6%
Land and buildings 22 €1,746 €1,499 -€247 -14.1%
Plant, machinery and equipment 23 €2,880 €233 -€2,646 -91.9%
Financial fixed assets 28 €60 €60 = 0.0%
Current assets 29/58 €144,430 €180,178 +€35,747 +24.8%
Stocks and contracts in progress 3 €78,030 €80,317 +€2,287 +2.9%
Stocks 30/36 €78,030 €80,317 +€2,287 +2.9%
Amounts receivable within one year 40/41 €42,482 €66,895 +€24,413 +57.5%
Trade receivables 40 €42,398 €55,687 +€13,289 +31.3%
Other amounts receivable 41 €84 €11,208 +€11,124 +13,310%
Cash at bank and in hand 54/58 €15,175 €32,777 +€17,602 +116%
Deferred charges and accrued income 490/1 €8,744 €189 -€8,555 -97.8%
Total equity and liabilities 10/49 €149,116 €181,970 +€32,854 +22.0%
Equity 10/15 €62,516 €54,478 -€8,038 -12.9%
Contributions 10/11 €7,000 €7,000 = 0.0%
Reserves 13 €55,516 €47,478 -€8,038 -14.5%
Distributable reserves 133 €55,516 €47,478 -€8,038 -14.5%
Amounts payable 17/49 €86,599 €127,491 +€40,892 +47.2%
Amounts payable after more than one year 17 €1,673 - -€1,673
Financial debts 170/4 €1,673 - -€1,673
Amounts payable within one year 42/48 €82,064 €125,252 +€43,188 +52.6%
Current portion of amounts payable after more than one year 42 €19,675 €1,673 -€18,002 -91.5%
Trade debts 44 €18,203 €47,838 +€29,636 +163%
Suppliers 440/4 €18,203 €47,838 +€29,636 +163%
Taxes, remuneration and social security 45 €15,155 €10,640 -€4,514 -29.8%
Taxes 450/3 €8,731 €4,001 -€4,730 -54.2%
Remuneration and social security 454/9 €6,424 €6,639 +€216 +3.4%
Other amounts payable 47/48 €29,031 €65,100 +€36,069 +124%
Accrued charges and deferred income 492/3 €2,862 €2,240 -€622 -21.7%
Non-recurring operating income 76A €9,306 - -€9,306
Remuneration, social security and pensions 62 €49,177 €51,965 +€2,788 +5.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,772 €2,893 +€121 +4.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €322 +€322
Other operating charges 640/8 €685 €727 +€41 +6.0%
Non-recurring operating charges 66A €1,461 - -€1,461
Gross operating margin 9900 €99,883 €51,464 -€48,419 -48.5%
Operating profit (loss) 9901 €45,787 -€4,443 -€50,230
Financial income 75/76B €338 €1,249 +€911 +270%
Recurring financial income 75 €338 €1,249 +€911 +270%
Financial charges 65/66B €6,389 €4,844 -€1,545 -24.2%
Recurring financial charges 65 €6,389 €4,844 -€1,545 -24.2%
Profit (loss) for the period before taxes 9903 €39,736 -€8,038 -€47,774
Income taxes 67/77 €11,477 - -€11,477
Profit (loss) for the period 9904 €28,259 -€8,038 -€36,297
Profit (loss) for the period to be appropriated 9905 €28,259 -€8,038 -€36,297
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.